188
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Inhibition of CDC42 reduces macrophage recruitment and suppresses lung tumorigenesis in vivo

, , ORCID Icon, , , , & show all
Pages 504-510 | Received 28 Aug 2020, Accepted 23 Sep 2020, Published online: 01 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qiang Feng, Jing Guo, Aijun Hou, Zhangli Guo, Yanmin Zhang, Yanhong Guo, Shasha Liu, Zhijie Cheng, Lixiao Sun, Ling Meng & Shasha Han. (2023) The clinical role of serum cell division control 42 in coronary heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 83:1, pages 45-50.
Read now

Articles from other publishers (8)

Mohammad Qasim Andrabi, Ilangovan Ramachandran, R. Ileng Kumaran & Satish Ramalingam. 2023. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research 875 892 .
Mohammad Qasim Andrabi, Ilangovan Ramachandran, R. Ileng Kumaran & Satish Ramalingam. 2022. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research 1 18 .
Yameng Yang, Li Huang & Bin Wu. (2022) Cell division control protein 42 correlates with lower disease risk and its elevation predicts better treatment response, and inhibits T-helper 17 cell differentiation in rheumatoid arthritis. Inflammopharmacology 30:6, pages 2117-2125.
Crossref
Shuquan Gao, Jun Xue, Xueliang Wu, Tingting Zhong, Yingchun Zhang & Shaodong Li. (2022) The relation of blood cell division control protein 42 level with disease risk, comorbidity, tumor features/markers, and prognosis in colorectal cancer patients. Journal of Clinical Laboratory Analysis 36:7.
Crossref
Xiaoyan Ming, Fan Yang & Hong Zhu. (2022) Blood CDC42 overexpression is associated with an increased risk of acute exacerbation, inflammation and disease severity in patients with chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine 24:3.
Crossref
Jun Yang, Xiaoqian Li, Xuefeng Yang, Hongjiang Wei, Lipu Deng & Nian Fu. (2022) Aberrant blood cell division cycle 42 expression and its correlation with disease severity, inflammation and mortality risk in patients with acute pancreatitis. Experimental and Therapeutic Medicine 24:1.
Crossref
Qian Zhang, Du Jin, Xiaoyue Mou & Hengli Ye. (2022) PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis. Journal of Clinical Laboratory Analysis 36:3.
Crossref
Mohammad Qasim Andrabi, Ilangovan Ramachandran, R. Ileng Kumaran & Satish Ramalingam. 2022. Handbook of Animal Models and its Uses in Cancer Research. Handbook of Animal Models and its Uses in Cancer Research 1 18 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.